3Wang Y,Moreira MD,Khan A,et al. Prognostic Significance of Circulating Levels of Hepatocyte Growth Factor in Patients with Chagas' Disease and Idiopathic Dilated Cardiomyopathy[J]. Cardiology, 2012,121(4):240-6.
4Nakamura T,Nawa K,Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats[J]. Biochem Biophys Res Commun,1984,12(3): 1450-9.
5Pratt N,Roughead EE. Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations: a retrospective cohort study[J]. Drug Aging,2010, 27(1): 63-71.
6Benhamou M,Gossec L. Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein[J]. Rheumtology,2010,49(3): 536-41.
7Falco H,Melvin S,Willem R. Intestinal permeability in irritablebowel syndrome patients:effects of NSAIDs[J]. Digest Dis Sci, 2010,55(3):716-23.
8KIM M D, HYUN D, BLEYS M D, et al. Risk of ischemic stroke associated with low-dose oral contraceptive use: a meta- analysis[J]. The Medicine Forum, 2011,7(1):21.
9CHAKHTOURA Z, CANONICO M, GOMPEL A, et al. Progestogen-only contraceptives and the risk of stroke a Meta- analysis[J]. Stroke, 2009,40(4) :1059-1062.
10NEWCOMER J W. Metabolic considerations in the use of anti- psychotic medications: a review of recent evidence [J]. The Journal of Clinical Psychiatry, 2007,68 : 20 27.
